21 November 2022 - DSM has announced it will halt vitamin A production in Sisseln, Switzerland, for at least two months commencing 2 January 2023.
Vitamin E 50% production will also be "significantly impacted", said the company, due to its common upstream infrastructure.
"At the start of the month November, DSM communicated to clients the necessity to enact price increases for its high-quality vitamins to justify continuation of production in Europe in the current challenging cost environment. With higher energy costs foreseen this winter, DSM has decided to halt Rovimix® Vitamin A production in Sisseln, Switzerland, which also impacts Rovimix® Vitamin E-50 production," the company said.
"Existing contractual commitments will be honoured, and allocation procedures have been activated across the global production network to enact this in an orderly manner," DSM added.
According to Feedinfo's Supply & Demand Database, the Sisseln plant has nameplate capacities of 5,600 tonnes/year for vitamin A 1000 and 18,000 tonnes/year for vitamin E oil used to manufacture vitamin E 50%.